1. Safety and efficacy of VRC01 broadly neutralising antibodies in adults with acutely treated HIV (RV397): a phase 2, randomised, double-blind, placebo-controlled trial. Issue 5 (May 2019) Authors: Crowell, Trevor A; Colby, Donn J; Pinyakorn, Suteeraporn; Sacdalan, Carlo; Pagliuzza, Amélie; Intasan, Jintana; Benjapornpong, Khunthalee; Tangnaree, Kamonkan; Chomchey, Nitiya; Kroon, Eugène; de Souza, Mark S; Tovanabutra, Sodsai; Rolland, Morgane; Eller, Michael A; Paquin-Proulx, Dominic; Bolto... Journal: Lancet Issue: Volume 6:Issue 5(2019) Page Start: e297 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗